Protein,Protein_definition,Disease_category,Disease,method,nsnp,OR [95% CI],Pvalue,QTL_type
CEMIP2,Cell surface hyaluronidase,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,Inverse variance weighted,69,1.04 [1.01-1.07],0.00436986785114775,trans
CEMIP2,Cell surface hyaluronidase,Chapter XI Diseases of the digestive system,K11_DISLIVOTH,Inverse variance weighted,3,1.05 [0.99-1.11],0.093255956315973,trans
CEMIP2,Cell surface hyaluronidase,Chapter XI Diseases of the digestive system,K11_LIVER,Inverse variance weighted,8,1.04 [0.98-1.1],0.183356674642318,trans
CEMIP2,Cell surface hyaluronidase,Chapter XI Diseases of the digestive system,K11_ALCOLIV,Inverse variance weighted,4,1.02 [0.98-1.07],0.240006845367856,trans
CEMIP2,Cell surface hyaluronidase,Chapter IX Diseases of the circulatory system,I9_HYPTENSPOR,Wald ratio,1,1.02 [0.98-1.06],0.293211050047958,trans
CEMIP2,Cell surface hyaluronidase,Chapter XI Diseases of the digestive system,CHIRHEP_NAS,Inverse variance weighted,2,1.01 [0.99-1.04],0.404133742616457,trans
CEMIP2,Cell surface hyaluronidase,Chapter VI Diseases of the nervous system,G6_POLYOTHUNS,Inverse variance weighted,2,1.03 [0.9-1.18],0.643511751731168,trans
CEMIP2,Cell surface hyaluronidase,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,Inverse variance weighted,3,1.01 [0.92-1.1],0.905173427579662,trans
